The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study

被引：0

作者：

Wen-Chien Cheng

Chi-Chien Lin

Wei-Chih Liao

Yu-Chao Lin

Chia-Hung Chen

Hung-Jen Chen

Chih-Yen Tu

Te-Chun Hsia

机构：

[1] China Medical University Hospital,Division of Pulmonary and Critical Care, Department of Internal Medicine

[2] China Medical University,School of Medicine, College of Medicine

[3] National Chung Hsing University,Department of Life Science

[4] National Chung Hsing University,PhD Program in Translational Medicine

[5] National Chung Hsing University,Rong Hsing Research Center for Translational Medicine

[6] National Chung-Hsing University,Institute of Biomedical Science, the iEGG and Animal Biotechnology Center, Advanced Plant and Food Crop Biotechnology Center

[7] Kaohsiung Medical University,Department of Pharmacology, College of Medicine

[8] Taichung Veterans General Hospital,Department of Medical Research

来源：

BMC Cancer | / 24卷

关键词：

Non-small cell lung cancer (NSCLC); Epidermal growth factor receptor (EGFR); Dacomitinib; Afatinib;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study
Cheng, Wen-Chien
Lin, Chi-Chien
Liao, Wei-Chih
Lin, Yu-Chao
Chen, Chia-Hung
Chen, Hung-Jen
Tu, Chih-Yen
Hsia, Te-Chun
BMC CANCER, 2024, 24 (01)
[2] Real-world study of dacomitinib as first-line treatment for patients with EGFR-mutant non-small cell lung cancer
Shin, J. E.
ANNALS OF ONCOLOGY, 2023, 34 : S1696 - S1697
[3] A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
Cam Phuong Pham
Thi Thai Hoa Nguyen
Anh Tu Do
Tuan Khoi Nguyen
Thi Anh Thu Hoang
Tuan Anh Le
Dinh Thy Hao Vuong
Dac Nhan Tam Nguyen
Van Khiem Dang
Thi Oanh Nguyen
Van Luan Pham
Minh Hai Nguyen
Thi Huyen Trang Vo
Hung Kien Do
Ha Thanh Vu
Thi Thuy Hang Nguyen
Van Thai Pham
Le Huy Trinh
Khac Dung Nguyen
Hoang Gia Nguyen
Cong Minh Truong
Tran Minh Chau Pham
Thi Bich Phuong Nguyen
BMC Cancer, 24
[4] A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
Pham, Cam Phuong
Nguyen, Thi Thai Hoa
Do, Anh Tu
Nguyen, Tuan Khoi
Hoang, Thi Anh Thu
Le, Tuan Anh
Vuong, Dinh Thy Hao
Nguyen, Dac Nhan Tam
Dang, Van Khiem
Nguyen, Thi Oanh
Pham, Van Luan
Nguyen, Minh Hai
Vo, Thi Huyen Trang
Do, Hung Kien
Vu, Ha Thanh
Nguyen, Thi Thuy Hang
Pham, Van Thai
Trinh, Le Huy
Nguyen, Khac Dung
Nguyen, Hoang Gia
Truong, Cong Minh
Pham, Tran Minh Chau
Nguyen, Thi Bich Phuong
BMC CANCER, 2024, 24 (01)
[5] Real-World Multicenter Experience of First-line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
Liam, C. K.
Chai, C.
Ho, G.
Alip, A.
Wahid, M. I. A.
Abdullah, M. M.
Foo, Y. C.
How, S. H.
Zaatar, A.
Lam, K. S.
Leong, K. W.
Low, J. S. H.
Yusof, M. Md
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S848 - S848
[6] A real-world experience of first-line afatinib in Korean patients with EGFR-mutant non-small cell lung cancer
Yoon, S. H.
Kim, Y. S.
Chung, J. H.
Seol, H. Y.
Kim, M. H.
ANNALS OF ONCOLOGY, 2019, 30
[7] Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
Liam, C.
Ho, G.
Chai, C.
Alip, A. Bt
Pang, Y.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S998 - S999
[8] Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
Shin, Ji Eun
Jung, Hyun Ae
Park, Sehhoon
Sun, Jong-Mu
Lee, Se-Hoon
Ahn, Jin Seok
Ahn, Myung-Ju
Shim, Byoung Yong
SCIENTIFIC REPORTS, 2025, 15 (01):
[9] Afatinib as First-Line Treatment in Elderly Patients with EGFR-Mutant Non-Small Cell Lung Cancer: Real-World Data Analysis
Chen, Yen-Ting
Yen, Chia-Te
Wu, Wen-Jui
Yang, Sheng-Hsiung
INTERNATIONAL JOURNAL OF GERONTOLOGY, 2022, 16 (03) : 266 - 270
[10] The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases
Van Pham, Thai
Vu, Thanh Ha
Nguyen, Hoa Thai Thi
Pham, Phuong Cam
Do, Anh Tu
Nguyen, Tuan Khoi
Hoang, Thi Anh Thu
Le, Tuan Anh
Vuong, Dinh Thy Hao
Nguyen, Dac Nhan Tam
Dang, Van Khiem
Nguyen, Thi Oanh
Pham, Van Luan
Nguyen, Minh Hai
Vo, Thi Huyen Trang
Mai, Khoa Trong
Do, Hung Kien
Nguyen, Thi Thuy Hang
Trinh, Le Huy
Nguyen, Hoang Gia
Truong, Cong Minh
Pham, Tran Minh Chau
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024,

← 1 2 3 4 5 →